Although the MK level is emerging as a very useful imaging marker in AD because it may strongly relate to the presence of an underlying amyloid pathology and neurodegeneration, we did not test the statuses of APOE-ε4, tau protein, or Aβ, reflecting a limitation and lack of completeness in our study. The gene discussed is MAPT; the disease is Alzheimer disease.